Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Funda Meric-Bernstam

Showing results (171-180 of 685) with videos related to

Pageof 69
Sort By:
American Journal of Surgery|April 26, 2008
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancerMin Yi, Savitri Krishnamurthy, Henry M Kuerer, et al.
Oncotarget|May 7, 2015
Epithelial to mesenchymal transition is associated with rapamycin resistanceAshley M Holder, Argun Akcakanat, Farrell Adkins, et al.
JAMA Oncology|September 8, 2018
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical TrialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket StudyJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer|September 7, 2006
Selective use of sentinel lymph node surgery during prophylactic mastectomyJudy C Boughey, Nazanin Khakpour, Funda Meric-Bernstam, et al.
JCO Clinical Cancer Informatics|July 3, 2019
OCTANE: Oncology Clinical Trial Annotation EngineJia Zeng, Md Abu Shufean, Yekaterina Khotskaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Reply to J.J. Tao et alJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast CancerWei Mo, Qingxin Liu, Curtis Chun-Jen Lin, et al.
Pageof 69

Showing results (171-180 of 685) with videos related to

Sort By:
Pageof 69
American Journal of Surgery|April 26, 2008
Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancerMin Yi, Savitri Krishnamurthy, Henry M Kuerer, et al.
Oncotarget|May 7, 2015
Epithelial to mesenchymal transition is associated with rapamycin resistanceAshley M Holder, Argun Akcakanat, Farrell Adkins, et al.
JAMA Oncology|September 8, 2018
Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical TrialAman U Buzdar, Vera J Suman, Funda Meric-Bernstam, et al.
Molecular Cancer Therapeutics|April 25, 2019
Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell HistiocytosisFilip Janku, Eli L Diamond, Aaron M Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 11, 2018
Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket StudyJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer|September 7, 2006
Selective use of sentinel lymph node surgery during prophylactic mastectomyJudy C Boughey, Nazanin Khakpour, Funda Meric-Bernstam, et al.
JCO Clinical Cancer Informatics|July 3, 2019
OCTANE: Oncology Clinical Trial Annotation EngineJia Zeng, Md Abu Shufean, Yekaterina Khotskaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 2, 2018
Reply to J.J. Tao et alJohn D Hainsworth, Funda Meric-Bernstam, Charles Swanton, et al.
Cancer Cell|July 29, 2006
BRIT1 regulates early DNA damage response, chromosomal integrity, and cancerRekha Rai, Hui Dai, Asha S Multani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2015
mTOR Inhibitors Suppress Homologous Recombination Repair and Synergize with PARP Inhibitors via Regulating SUV39H1 in BRCA-Proficient Triple-Negative Breast CancerWei Mo, Qingxin Liu, Curtis Chun-Jen Lin, et al.
Pageof 69